Company news
Marijuana Inc. news in 2025
Marijuana Inc.'s news releases, calls and decks from 2025, newest first.
Exousia Pro, Inc. Announces Executed LOI for Strategic Acquisition of High-Revenue Telehealth Platform to Accelerate Nutraceutical Commercialization
December 11, 2025
Exousia Pro, Inc. Revolutionizes Nutraceuticals With Launch Of Maxasome(TM): The First All-Natural, Biologically Active Exosomal Supplement
December 5, 2025
Exousia Pro, Inc. Completes Exclusive Licensing Agreement With the University of Central Florida for Novel Cancer Diagnostic and Therapy Platforms
December 2, 2025
Exousia Pro Initiates Strategic Realignment, Acquires Controlling Stake in SEC-Reporter Lamy (LMMY) in All-stock Exchange Transaction for Exousia AI, to Advance Growth and Enhance Shareholder Value
November 17, 2025
Exousia Pro Announces Breakthrough In Exosome-Based Delivery
November 4, 2025
Exousia Pro is Excited to Announce that it has Received Orphan Drug Designation from the FDA
October 28, 2025
Exousia Pro Announces Groundbreaking Study to Revolutionize the Global Edibles Market with CBD-Loaded Exosomes
September 29, 2025
Exousia Pro Reports Positive Outcome in Legal Proceeding
September 26, 2025
Exousia Pro Files Provisional Patent for Novel Extracellular Vesicle Loading Method, Tapping into Multi-Billion Dollar Markets
September 10, 2025
Exousia Pro Announces Strategic Acquisition to Launch a New Telehealth Division
September 8, 2025
Exousia Pro Creates New Subdivisions
September 3, 2025
Exousia Pro Files Reg A.
June 25, 2025
Exousia Pro Expands its Scientific Advisory Board
June 18, 2025
Exousia Pro Will Launch a Web Series with Our New Consultant
April 30, 2025
Exousia Pro Finishes Preclinical Trial for Glioblastoma Ahead of Schedule - Bolstering Orphan Drug Application
April 29, 2025
Exousia Pro CSO Revealed Significant Findings About the Glioblastoma Study in a Spaces Interview
April 20, 2025
Exousia Pro Offers Guidance on New Subdivisions
April 16, 2025
Exousia Pro to Deliver 500 Billion Dried Exosomes for Trade Show
April 7, 2025
Exousia Pro Issues Update on Name Change
April 2, 2025
Exousia Pro Has Appointed Matthew Dwyer As Its New President
April 1, 2025
Exousia Pro Issues and Update on its FDA Orphan Drug Status
March 31, 2025
Exousia Pro Officially Announces the Production of Plant-Based Exosomes Has Begun
March 24, 2025
Marijuana, Inc., Completes Acquisition of Exousia AI and Enters Expanding Exosome Market
January 5, 2025